A+ | A | A- | Skip to main content |

800 years stamp

Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Thursday, 11 June 2026 02:33 AM	Asian-Paints2680.30	Hind-Unilever2147.80	ITC282.55	Trent2714.00	Larsen-and-Toubro3871.55	M-and-M3000.65	Reliance-Industries1267.40	Tata-Steel197.85	Titan-Company4047.70	SBI1005.00	Bharat-Electron403.60	Kotak-Mah-Bank394.70	Infosys1118.20	Bajaj-Finance871.85	Sun-PharmaInds1794.00	HDFC-Bank747.15	TCS2136.90	ICICI-Bank1320.20	Power-Grid-Corpn286.75	Maruti-Suzuki13136.00	Axis-Bank1321.75	HCL-Technologies1110.20	NTPC351.10	Bharti-Airtel1785.70	Tech-Mahindra1464.40	Adani-Ports1795.00	UltraTech-Cem10862.35	Bajaj-Finserv1649.90	Interglobe-Aviat4491.80	Eternal236.55
15 mins delay SENSEX 74,086.53 [103.35]	-34.55 -1.27%	-21.50 -0.99%	-1.20 -0.42%	-38.80 -1.41%	-45.80 -1.17%	48.75 1.65%	7.85 0.62%	-1.20 -0.60%	8.35 0.21%	1.70 0.17%	-4.85 -1.19%	6.70 1.73%	-26.85 -2.34%	-12.20 -1.38%	6.90 0.39%	0.15 0.02%	-17.00 -0.79%	26.95 2.08%	-0.50 -0.17%	59.95 0.46%	7.15 0.54%	-21.85 -1.93%	-0.50 -0.14%	10.30 0.58%	-14.10 -0.95%	-27.05 -1.48%	-3.80 -0.03%	-14.15 -0.85%	-31.75 -0.70%	-3.05 -1.27%

Corporate News

Latest News about business and investments.

Glenmark launches Winlevi' in key European markets

11-Jun-26 12:32Hrs IST

Glenmark Specialty S.A (GSSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals, today announced the launch of Winlevi' (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in adolescents limited to facial application) by the European Commission to Cassiopea S.p.A., a subsidiary of Cosmo N.V. (SIX: COPN) (Cosmo) in October 2025.

Glenmark has initiated direct launches in several European markets, including the Nordics, Central and Eastern Europe, and Spain. In Portugal, the Company has launched the product through a strategic partner. Glenmark is also advancing additional launches through strategic partnerships across other European markets.

The product is authorized in the European Union for the treatment of acne vulgaris in adults and adolescents. The product has been developed by Cassiopea, which holds rights across Europe and collaborates with regional partners for commercialization.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise